Zoledronic Acid Infusion
Product Name: Zoledronic Acid Infusion
Common Name: Zoledronic Acid
Strength: 5 mg/100 ml vial
Description:
Zoledronic Acid Infusion is a bisphosphonate used to treat a variety of bone conditions, including osteoporosis and bone complications from cancer. It works by inhibiting the activity of osteoclasts, cells that break down bone tissue, thereby helping to maintain bone strength and reduce the risk of fractures. Zoledronic acid is also used to lower high calcium levels in the blood (hypercalcemia) that can occur with certain cancers.
Zoledronic Acid Infusion is typically administered as a slow intravenous infusion and is highly effective in preventing bone loss, treating bone metastases, and managing the effects of bone-related cancers.
Indications and Usage:
Zoledronic Acid Infusion is indicated for:
- Treatment of osteoporosis in postmenopausal women and men at increased risk of fractures.
- Prevention of skeletal-related events (e.g., fractures) in patients with bone metastases from solid tumors.
- Treatment of hypercalcemia of malignancy.
- Management of Paget’s disease of the bone.
- Treatment of glucocorticoid-induced osteoporosis.
Features:
- Potent bisphosphonate for treating and preventing bone loss.
- Reduces the risk of fractures in osteoporosis patients.
- Lowers elevated calcium levels in patients with cancer-related hypercalcemia.
- Administered as a single intravenous infusion, typically every year for osteoporosis or more frequently for cancer-related conditions.
- Safe and effective for use in both men and women with bone complications.
Pack Size: Zoledronic Acid Infusion is available in 100ml vial.
Minimum Order Quantity: 3000 packs
Certification: WHO-GMP
